Empowering New Zealand Nurses for Excellence in Healthcare
Bicultural Structure
Membership includes belonging to a bicultural organisation focused on professional nursing issues and community health.
Insurance Coverage
Members receive up to $1 million indemnity insurance in New Zealand (not applicable for retired members). (Conditions apply).
Access to Publications
Members have access to the ‘Nursing Praxis in Aotearoa New Zealand’ journal.
Influence and Networking
Members contribute to a significant influencer in health policy decision-making and join a dynamic network of professional nurses committed to high standards of practice.
17 March 2026
Beta-blockers not effective after MI when ejection fraction is preserved
The benefit of beta‑blockers after myocardial infarction in patients with preserved left ventricular ejection fraction (LVEF ≥50%) is uncertain. This individual‑patient meta‑analysis combined five open‑label randomised trials, including 17,801 patients without other indications for beta-blockers 1 . Participants were assigned to beta‑blocker therapy or no therapy, and the primary outcome was a composite of all‑cause death, myocardial infarction, or heart failure. After a median 3.6‑year...
16 March 2026
Pharmac seeks feedback on the Exceptional Circumstances Framework
We are getting in touch to let you know that Pharmac is seeking feedback on the Exceptional Circumstances Framework (the Framework), and we’d like to hear from you. The Framework outlines how Pharmac considers funding requests for people with exceptional clinical circumstances when those circumstances fall outside the Pharmaceutical Schedule funding process. Patients, whānau, clinicians, and others have told us that the current Framework is no longer fit for purpose and can be difficult to...
16 March 2026
Associate Professor in Nursing
Are you an experienced nursing academic with a strong record in teaching, research, and academic leadership? Do you want to help shape the future nursing workforce in Aotearoa through research-informed education, innovation, and collaboration with the health sector? This is an exciting opportunity to join the School of Nursing and Midwifery at the University of Waikato and contribute to the development of a highly skilled, culturally responsive nursing workforce. Ngā kōrero mō te tūranga -...
16 March 2026
Leadership Opportunity for experienced RN in Mental Health
Leadership opportunity for an experienced Registered Nurse in mental health $105,812 + complexity allowance + 5 weeks AL + 2 paid well-being days HealthNow Payment Card - $250 per year + Increased KiwiSaver contribution Great leadership opportunity - Registered Nurse with experience in mental health to lead our Nelson based Respite service. What we offer | Ngā āhuatanga kei a mātou $105,812 + complexity allowance Increased Kiwisaver contribution Fifth week of Annual Leave (after 12...
16 March 2026
Pharmac Update: Primary Care Prescribers | 13 March 2026
Below is the latest information on Pharmac consultations, notifications, and supply issues for Primary Care Prescribers for week 13 March 2026. It includes information on: New updates Resolved Supply Issues Supply issue: hydrocortisone 5mg + cinchocaine 5mg (Proctosedyl) Suppositories An expected shipment has been delayed. This has resulted in a supplier out of stock of Proctosedyl suppositories. Proctosedyl ointment is available. Ultraproct suppositories have been out of stock for a long...
15 March 2026
Goodfellow Symposium
Hurry and secure your place this weekend We invite all primary care professionals to New Zealand’s premier professional development event for general practice and primary care. Event Overview: 📅 March 2026 21-22 Due Drop Events Centre, Manukau Programme highlights : Hear from leading experts and our partners the Royal NZ College of GPs, the Royal NZ College of Urgent Care, and Allevia Hospitals - with a line-up that blends essential updates, fresh perspectives, and practice-changing...
15 March 2026
13 March 2026 | Updates on Supply Issues
New medicine supply notices Flumetasone pivalate (Locorten-Vioform) ear drops (Pharmacode 259799) There will be an out of stock until at least August 2026. The alternatives are Kenacomb (Pharmcode: 253634) and Sofradex (a part charge applies to Sofradex) (Pharmacode: 208728). Sodium Fusidate [fusidic acid] (Foban) Oint 2% (Pharmacode 2556189) The ointment may go out of stock. There is ample supply of the cream (Pharmacode: 2556170) to use as an alternative. Updated medicine supply notices...
15 March 2026
Medicinal cannabis products that meet the minimum quality standard: Medicinal cannabis products that meet the minimum quality standard: Beacon Medical teas
The Misuse of Drugs (Medicinal Cannabis) Regulations 2019 (the Regulations) set the minimum quality standard that medicinal cannabis products and ingredients must meet before they can be supplied in New Zealand. Importers, manufacturers, and suppliers must apply for assessment and provide evidence to the Medicinal Cannabis Agency to verify that their products meet the minimum quality standard. Beacon Medical GSC THC20 CBD≤1 has been verified as meeting the minimum quality standard. Beacon...
11 March 2026
Nurse Practitioner - Waikato
Nurse Practitioner – Full or Part Time Residential Eldercare Services 🌟 Join Our Exceptional Team as a Nurse Practitioner! 🌟 Are you passionate about providing the highest standard of care to the elderly? Do you thrive in a collaborative and supportive work environment? We have an exciting job opportunity for Nurse Practitioners to join our unique totally mobile general practice dedicated to eldercare. At Residential Eldercare Services, we believe in fostering a dynamic and fulfilling...
11 March 2026
Pharmac proposal: Updating the Pharmaceutical Schedule for ambulance medicines, and tenecteplase for pre-hospital care
From 1 July 2026, Pharmac will take over responsibility for funding medicines used in ambulances. This consultation seeks feedback on changes to the Pharmaceutical Schedule which supports this decision. Bringing ambulance medicines into the Pharmaceutical Schedule will help to ensure a more coordinated approach to funding and procurement decisions for emergency medicines, whether they are used in hospitals, ambulances or by PRIME providers. Under this proposal, we would also fund tenecteplase...
11 March 2026
Decision to widen access to brentuximab vedotin for systemic anaplastic large cell lymphoma
We have made the decision to widen access to brentuximab vedotin for systemic anaplastic large cell lymphoma from 1 April 2026 . We expect this will improve the lives of around 12-13 people in New Zealand per year.Thank you to all those who provided feedback in response to the consultation, your feedback is appreciated. You can find more information on this decision on the Pharmac website including our responses to key points raised by consultees. Decision to widen access to brentuximab...
10 March 2026
Decision to widen access to existing medicines and fund a new medicine for the treatment of cystic fibrosis
Pharmac has made a decision to widen access to Trikafta and Kalydeco, and to fund Alyftrek for the treatment of cystic fibrosis.From 1 April 2026, the following changes will be implemented for people with eligible mutations: Widened access to Trikafta (elexacaftor/tezacaftor/ivacaftor) Widened access to Kalydeco (ivacaftor) Funding of a new medicine, Alyftrek (vanzacaftor/tezacaftor/deutivacaftor) This decision follows consultation with people with cystic fibrosis, their families, healthcare...
10 March 2026
Continuing Professional DevelopmentPodcasts | Webinars | Gems | eLearning | MedCases
Dear Andrea, NEXT WEEK! Goodfellow Symposium 2026 And while we wait, here are our latest webinars and podcasts: Functional gastrointestinal conundrums: Utilising the MDT WEBINAR 17 March: The team from Allevia Hospitals will distil key practical tips and demonstrate how a team-based, multidisciplinary approach can help clinicians manage common GI conundrums more effectively. Register here Adult ADHD in practice: A clinical Q&A WEBINAR 19 March: Join David Codyre for an entire...
10 March 2026
Supply Issue: Ticagrelor tab 90 mg (Sandoz)
Kia ora Supply Issue: We are writing to inform you that due to shipping delays, Sandoz expects to run out of ticagrelor 90mg tab by mid-March 2026. Key Dates: It is estimated that ticagrelor 90mg tab (Sandoz) stock will be depleted by mid-March An alternative brand Ticagrelor Mylan 90mg tab was listed from 1 March 2026 Key messages: Ticagrelor Mylan is from the Italian market. The box will be over labelled with English text, and the blister packs have Italian text. Ticagrelor Mylan...
9 March 2026
Pharmac Update: Primary Care Prescribers | 06 March 2026
Below is the latest information on Pharmac consultations, notifications, and supply issues for Primary Care Prescribers for week 06 March 2026. It includes information on: New updates Resolved Supply Issues Changes to antiretroviral dispensing – effective 1 March 2026 From 1 March 2026, all listed antiretroviral (Community Schedule) treatments changed to 90‑day dispensing and may be prescribed and dispensed accordingly where appropriate. Supply issue: ticagrelor tab 90 mg (Sandoz) Due to...
9 March 2026
Conflict in the Middle East: Impact on the supply chain
Pharmac has asked suppliers to notify us early of any supply risks, so we can act sooner and support ongoing access to medicines and medical devices. Read more Have your say We’re consulting on upcoming changes to how the Pharmaceutical Schedule will work. Changes to how the Pharmaceutical Schedule will work (consultation closes 13 March 2026) New medicine supply notices Proctosedyl (suppositories) Unfortunately, AFT (the supplier) has run out of Proctosedyl suppositories (Pharmacode:...
Areas of interest
